ShockWave Medical says HSR Act waiting period expired on May 20

In a regulatory filing, Shockwave Medical stated: “As previously announced, on April 4, 2024, Shockwave Medical entered into an Agreement and Plan of Merger with Johnson & Johnson, a New Jersey corporation, and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson & Johnson, providing for the merger of Merger Sub with and into Shockwave, with Shockwave surviving the Merger as a wholly owned subsidiary of Johnson & Johnson. The closing of the Merger is conditioned upon, among other things, the expiration or termination of the waiting period applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Shockwave and Johnson & Johnson each made the necessary filings under the HSR Act with the Antitrust Division of the U.S. Department of Justice and the U.S. Federal Trade Commission on April 18, 2024. The required waiting period under the HSR Act with respect to the Merger expired at 11:59 p.m., Eastern Time on May 20, 2024. The expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the Merger.” The company notes that the closing of the merger remains subject to the satisfaction or waiver of other customary closing conditions and as previously announced, Shockwave has scheduled the special meeting of stockholders for May 29 to vote on adoption of the merger agreement.